PVCT Exercise Disclosure
Pershing Edward · SEC Form 4 · Filed Sep 18, 2026
Exercise
Calculated transaction value
$0
Pershing Edward CEO
PVCT
Transaction date
Sep 18, 2026
Public filing date
Sep 18, 2026
Filing lag
Filed same day
PVCT daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Series D-1 Convertible Preferred Stock on Common Stock
- Quantity / price
- 13,216 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001493152-26-043276
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Provectus Biopharmaceuticals, Inc. PVCT Current | Exercise | Sep 18, 2026 | $0 |
| Provectus Biopharmaceuticals, Inc. PVCT | Exercise | Sep 18, 2026 | Not reported |